These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 4102807)

  • 61. Measles outbreaks in Australia: obstacles to vaccination.
    Dawson B; Apte SH
    Aust N Z J Public Health; 2015 Apr; 39(2):104-6. PubMed ID: 25715740
    [No Abstract]   [Full Text] [Related]  

  • 62. Age of measles immunization in tropics.
    Mirchamsy H; Shafyi A; Mahinpour M; Nazari P
    Dev Biol Stand; 1978; 41():191-4. PubMed ID: 572788
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Measles in previously vaccinated children. Evaluation of an outbreak.
    Currier RW; Hardy GE; Conrad JL
    Am J Dis Child; 1972 Dec; 124(6):854-7. PubMed ID: 4639221
    [No Abstract]   [Full Text] [Related]  

  • 64. [Unsuitability of children revaccination against measles].
    Bolotovskiĭ VM; Titova NS
    Sov Med; 1981; (9):43-8. PubMed ID: 7313794
    [No Abstract]   [Full Text] [Related]  

  • 65. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Studies of specific measles prevention].
    Cajal N; Cepleanu M; Sorodoc Y; Cernescu C; Manu S; Weintraub B; Lucian M; Popescu M
    Stud Cercet Inframicrobiol; 1970; 21(3):195-211. PubMed ID: 5455840
    [No Abstract]   [Full Text] [Related]  

  • 67. [Duration and degree of immunity in children vaccinated against measles].
    Klimovitskaia VE; Plotkina II; Iasina GE; Shavrova AI; Iasin AE
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Oct; (10):56-9. PubMed ID: 4454829
    [No Abstract]   [Full Text] [Related]  

  • 68. The role of secondary vaccine failures in measles outbreaks.
    Mathias RG; Meekison WG; Arcand TA; Schechter MT
    Am J Public Health; 1989 Apr; 79(4):475-8. PubMed ID: 2929807
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Measles antibody levels in a vaccinated population in Brazil.
    Cox MJ; Azevedo RS; Massad E; Fooks AR; Nokes DJ
    Trans R Soc Trop Med Hyg; 1998; 92(2):227-30. PubMed ID: 9764341
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Determination of measles immunity after a mass immunization campaign.
    Levitt LP; Case GE; Neil JS; Casey HL; Adler P; Ferreri S; Witte JJ
    Public Health Rep (1896); 1970 Mar; 85(3):261-5. PubMed ID: 4984891
    [No Abstract]   [Full Text] [Related]  

  • 71. Measles mortality and vaccine efficacy in rural West Africa.
    Hull HF; Williams PJ; Oldfield F
    Lancet; 1983 Apr; 1(8331):972-5. PubMed ID: 6132278
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Analysis of the incidence of measles in Bratislava before and after introduction of vaccination (author's transl)].
    Ferencei M; Holanová J; Dimitrova E
    Bratisl Lek Listy; 1976 Jun; 65(6):659-71. PubMed ID: 974833
    [No Abstract]   [Full Text] [Related]  

  • 73. Measles (rubeola) susceptibility among elementary schoolchildren.
    Kalis JM; Quie PG; Balfour HH
    Am J Epidemiol; 1975 Jun; 101(6):527-31. PubMed ID: 1155431
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Measles vaccination in tropical countries.
    Griffith AH
    Trans R Soc Trop Med Hyg; 1975; 69(1):29-30. PubMed ID: 806999
    [No Abstract]   [Full Text] [Related]  

  • 75. [Immunologic structure of the population characterizing measles susceptibility and its change with massive active immunization].
    Tsipershtein MIa; Shekhter AB
    Zh Mikrobiol Epidemiol Immunobiol; 1972 May; 49(5):39-42. PubMed ID: 5037761
    [No Abstract]   [Full Text] [Related]  

  • 76. Measles vaccines.
    Dudgeon JA
    Br Med Bull; 1969 May; 25(2):153-8. PubMed ID: 4918530
    [No Abstract]   [Full Text] [Related]  

  • 77. Measles IgM response during reinfection of previously vaccinated children.
    Linnemann CC; Hegg ME; Rotte TC; Phair JP; Schiff GM
    J Pediatr; 1973 May; 82(5):798-801. PubMed ID: 4698953
    [No Abstract]   [Full Text] [Related]  

  • 78. Measles vaccination. V. The booster effect of purified hemagglutinin in children previously immunized with this product or formalin-killed vaccine.
    Norrby E; Lagercrantz R; Gard S
    Acta Paediatr Scand; 1966 Jan; 55(1):73-8. PubMed ID: 5919475
    [No Abstract]   [Full Text] [Related]  

  • 79. Risk factors for measles and vaccine efficacy during an epidemic in Montreal.
    Rivest P; Bédard L; Arruda H; Trudeau G; Remis RS
    Can J Public Health; 1995; 86(2):86-90. PubMed ID: 7757898
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Characteristics of measles epidemics in the Donetsk region population under conditions of regular immunization].
    Slusar' LI; Kolomiĭtseva GN; Erokhina EV; Belomeria TA; Soshenko II; Kovaleva AG
    Lik Sprava; 2002; (2):123-5. PubMed ID: 12073243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.